Evaluation of voriconazole related adverse events in pediatric patients with hematological malignancies.

Ertem, Ozge; Tufekci, Ozlem; Oren, Hale; Tuncok, Yesim; Ergon, Mahmut Cem; Gumustekin, Mukaddes

Ertem, Ozge; Tufekci, Ozlem; Oren, Hale; Tuncok, Yesim; Ergon, Mahmut Cem; Gumustekin, Mukaddes.

Afiliação

Ertem O; Medical Pharmacology, University of Health Sciences Izmir Bozyaka Education and Research Hospital, Karabaglar/Izmir, Turkey.
Tufekci O; Division of Pediatric Hematology, Department of Pediatrics, Dokuz Eylul University School of Medicine, Balcova/Izmir, Turkey.
Oren H; Division of Pediatric Hematology, Department of Pediatrics, Dokuz Eylul University School of Medicine, Balcova/Izmir, Turkey.
Tuncok Y; Department of Medical Pharmacology, Dokuz Eylul University School of Medicine, Balcova/Izmir, Turkey.
Ergon MC; Department of Medical Microbiology, Dokuz Eylul University School of Medicine, Balcova/Izmir, Turkey.
Gumustekin M; Department of Medical Pharmacology, Dokuz Eylul University School of Medicine, Balcova/Izmir, Turkey.

J Oncol Pharm Pract ; 29(4): 861-873, 2023 Jun.

Article em En | MEDLINE | ID: mdl-35285751

Assuntos

Antifúngicos; Neoplasias Hematológicas; Humanos; Criança; Voriconazol/efeitos adversos; Antifúngicos/efeitos adversos; Estudos Retrospectivos; Estudos Prospectivos; Neoplasias Hematológicas/tratamento farmacológico

Palavras-chave

Voriconazole; adverse events; adverse reactions; invasive fungal infection; pediatrics

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Hematológicas / Antifúngicos Tipo de estudo: Observational_studies / Prognostic_studies Limite: Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google